Early detection of metastatic uveal melanoma by the analysis of tumor ‐specific mutations in cell‐free plasma DNA

ConclusionDetection of ctDNA in plasma can provide a diagnostic lead time over the clinical diagnosis of metastases or tumor recurrence. Longer lead times are to be expected if intervals between sampling are shortened.

Source: Cancer Medicine - July 22, 2021 Category: Cancer & Oncology Authors: Claudia H. D. Le Guin, Norbert Bornfeld, Nikolaos E. Bechrakis, Leyla Jabbarli, Heike Richly, Dietmar R. Lohmann, Michael Zeschnigk Tags: RESEARCH ARTICLE Source Type: research